0000886163-22-000079.txt : 20220613
0000886163-22-000079.hdr.sgml : 20220613
20220613184536
ACCESSION NUMBER: 0000886163-22-000079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220610
FILED AS OF DATE: 20220613
DATE AS OF CHANGE: 20220613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAMATTINA JOHN L
CENTRAL INDEX KEY: 0001216074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 221012965
MAIL ADDRESS:
STREET 1: 81 WYMAN ST
STREET 2: POST OFFICE BOX 9046
CITY: WALTHAM
STATE: MA
ZIP: 02454
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-06-10
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001216074
LAMATTINA JOHN L
5980 HORTON STREET, SUITE 405
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2022-06-10
4
A
0
1004
0.0
A
26402
D
Non-Qualified Stock Option (right to buy)
79.29
2022-06-10
4
A
0
4340
0.0
A
2032-06-10
Common Stock
4340
4340
D
Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
By: Charles S. Berkman For: John L. LaMattina
2022-06-13